{
    "clinical_study": {
        "@rank": "35184", 
        "acronym": "PHIPS", 
        "brief_summary": {
            "textblock": "Data from large prospective cohort studies of prosthetic joint infections are lacking.\n\n      Aim of this study: analyzing prospectively the incidence of reinfection in patients with\n      prosthetic hip infections who underwent surgery and received antibiotic therapy.\n\n      Hypothesis: to confirm in a large group that the incidence of reinfection after excision\n      -synovectomy in acute prosthesis hip infection is 30% and 15% for chronic infection after\n      exchange arthroplasty (one or two stage exchange)."
        }, 
        "brief_title": "Prosthetic Hip Infections: Prospective Study", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": "Hip Prosthesis Infection.", 
        "detailed_description": {
            "textblock": "Aim of the study: to analyze the incidence of reinfection in patients with prosthetic hip\n      infection who underwent surgery and received antibiotic therapy Methods: prospective cohort\n      study in a French referral center for osteoarticular infections from November 2002 to March\n      2010. Population\n\n        -  all patients who consented to participate in the study with prosthetic hip infections\n           treated  by:\n\n        -  debridement-synovectomy for acute infection or with one-stage or two-stage\n\n        -  exchange arthroplasty or resection arthroplasty for chronic infection\n\n        -  antibiotic therapy\n\n      Outcome:\n\n        -  Follow-up: minimum of 2 years\n\n        -  Events monitored: reinfection including relapse and new infection, joint revision for\n           mechanical reasons, prosthetic hip infection related and non-related deaths"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with hip arthroplasty infection\n\n          -  Surgical treatment: either debridement-synovectomy and prosthesis retention for acute\n             infection or one or two-stage exchange arthroplasty or resection arthroplasty for\n             chronic infection\n\n          -  Antibiotic therapy\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Prolonged suppressive antibiotic therapy\n\n          -  No surgical treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with hip arthroplasty infection who underwent surgery and received antibiotic\n        therapy in a specialized French orthopaedic center for bone and joint infection."
            }
        }, 
        "enrollment": {
            "#text": "347", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963520", 
            "org_study_id": "GHDCSS-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hip prosthesis infection", 
            "Reinfection", 
            "Excision-synovectomy", 
            "One stage/two stage revision", 
            "Antibiotherapy"
        ], 
        "lastchanged_date": "October 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75020"
                }, 
                "name": "Diaconesses Croix Saint-Simon Hospital Group"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Study of Patients Treated for Prosthetic Hip Infection and Followed for at Least 2 Years", 
        "overall_official": {
            "affiliation": "Diaconesses Croix Saint-Simon Hospital Group, Paris, France", 
            "last_name": "Valerie ZELLER, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France : Agence nationale de S\u00e9curit\u00e9 du m\u00e9dicament : ANSM", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The aim of this study was to prospectively determine the incidence of reinfection in patients with prosthetic hip infection after two years of follow up.", 
            "measure": "Incidence of reinfection (relapse and new infection)", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963520"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Groupe Hospitalier Diaconesses Croix Saint-Simon", 
            "investigator_full_name": "Dr Valerie ZELLER", 
            "investigator_title": "Investigator coordinator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "8609130", 
            "citation": "Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996 Apr;78(4):512-23."
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence and causes of mechanical revision", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Incidence and causes of death: infection or treatment related death, unrelated death", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Groupe Hospitalier Diaconesses Croix Saint-Simon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Groupe Hospitalier Diaconesses Croix Saint-Simon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2002", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}